Cancers of the Head and Neck Not Yet Recruiting Phase 1 Trials for Retifanlimab (DB15766)

Also known as: Cancer of the Head and Neck

IndicationStatusPhase
DBCOND0065283 (Cancers of the Head and Neck)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04470024Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCCTreatment